Alnylam Pharmaceuticals, Inc. (ALNY)

318.85 -9.88 (-3.01%) USD  |  NASDAQ  |  Apr 02, 16:00
318.65 -0.20 (-0.06%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Total Depreciation, Amortization, Depletion (Semi Annual)

Total Depreciation, Amortization, Depletion (Semi Annual) Chart

View Total Depreciation, Amortization, Depletion (Semi Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Depreciation, Amortization, Depletion (Semi Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Depreciation, Amortization, Depletion (Semi Annual) Range, Past 5 Years

View Total Depreciation, Amortization, Depletion (Semi Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Depreciation, Amortization, Depletion (Semi Annual) Benchmarks

View Total Depreciation, Amortization, Depletion (Semi Annual) Benchmarks
Start Trial
Pfizer Inc. --
Eli Lilly & Co. --
Bristol Myers Squibb Co. --
Ionis Pharmaceuticals, Inc. --
Regeneron Pharmaceuticals, Inc. --